Kaya Holdings (KAYS) Convertible Debt (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly Convertible Debt of $59312.0 in Q3 2025, down 99.32% quarter-over-quarter from $8.7 million in Q2 2025, and down 99.27% on a YoY basis from $8.1 million in Q3 2024.
Kaya Holdings (KAYS) Convertible Debt (2014 - 2025) Analysis & Trends
Kaya Holdings' Convertible Debt history runs 12 years deep, the most recent figure standing at $59312.0 for Q3 2025.
- In Q3 2025, Convertible Debt fell 99.27% year-over-year to $59312.0; the TTM figure through Sep 2025 stood at $59312.0 (down 99.27% YoY), while the FY2024 annual figure was $70920.0, down 99.03% from the prior year.
- Convertible Debt was $59312.0 for Q3 2025 at Kaya Holdings, down from $8.7 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $8.7 million in Q2 2025 to a low of $59312.0 in Q3 2025.
- Historically, Convertible Debt has averaged $4.6 million across 5 years, with a median of $7.1 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Convertible Debt jumped 5593.38% in 2022, then sank 99.27% in 2025.
- A 5-year view of Convertible Debt shows it stood at $7.0 million in 2021, then advanced by 6.61% to $7.4 million in 2022, then dropped by 1.45% to $7.3 million in 2023, then slumped by 99.03% to $70920.0 in 2024, then decreased by 16.37% to $59312.0 in 2025.
- The last three Convertible Debt figures came in at $59312.0 (Q3 2025), $8.7 million (Q2 2025), and $70920.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 59,312.00 |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 70,920.00 |
| Dec 31, 2024 | 70,920.00 |
| Sep 30, 2024 | 8.09 Mn |
| Jun 30, 2024 | 509,312.00 |
| Mar 31, 2024 | 7.66 Mn |
| Dec 31, 2023 | 7.31 Mn |
| Sep 30, 2023 | 7.34 Mn |
| Jun 30, 2023 | 7.27 Mn |
| Mar 31, 2023 | 7.21 Mn |
| Dec 31, 2022 | 7.42 Mn |
| Jun 30, 2022 | 7.12 Mn |
| Mar 31, 2022 | 7.00 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 125,000.00 |
| Mar 31, 2021 | 175,000.00 |
| Dec 31, 2020 | 6.40 Mn |
| Sep 30, 2020 | 354,073.00 |